FDA DEVICE FACTS
NIRA Beauty Skin Laser
Dermal Photonics Corporation
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The NIRA Laser is indicated for the treatment of periorbital wrinkles.
The LOI System is an over-the-counter device intended for treatment of periorbital wrinkles. OTC Yes Yes
Similarities The NIRA Laser has similar indications for use, is an OTC device and uses a similar wavelength as the predicate device.
The NIRA Laser has similar clinical efficacy three (3) months after users stopped using NIRA, similar to the Palomar LOI System.
Like the predicate device, the NIRA Laser meets all electrical, EMC, or Laser, and FCC testing requirements.
Differences Differences between the NIRA Laser and the predicate devices include: Pulse/treatment duration Treatment schedules
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。